Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4270)
All Articles published online
|
Jun 14, 2007 (publication date) through Jan 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Velu V, Nandakumar S, Shanmugam S, Jadhav SS, Kulkarni PS, Thyagarajan SP. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India. World J Gastroenterol 2007; 13(22): 3084-3089 [PMID: 17589924 DOI: 10.3748/wjg.v13.i22.3084] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i22/3084.htm |
| Number | Citing Articles |
| 1 |
Nina Genéviève Mathuola Ouattara, Armel Moumouni Sanou, Delphine Napon-Zongo, Abou Coulibaly, Sylviane Korogho, Abdoulaye Dera, Achille S. Nikièma, Eric Kyelem, Nawatou Gansoré, Abdoul Kader Ilboudo, Jeoffray Diendéré, Gautier Henri Ouédraogo. Immune response to GeneVac-BⓇ (rDNA I.P. hepatitis B vaccine) in vaccinated persons with a standard schedule in Bobo-Dioulasso, Burkina Faso. IJID Regions 2024; 13: 100483 doi: 10.1016/j.ijregi.2024.100483
|
| 2 |
N.Y. Rots, A.J. Wijmenga-Monsuur, W. Luytjes, P. Kaaijk, T.W. de Graaf, B.A.M. van der Zeijst, C.J.P. Boog. Hepatitis B vaccination strategies tailored to different endemicity levels: Some considerations. Vaccine 2010; 28(4): 893 doi: 10.1016/j.vaccine.2009.10.125
|
| 3 |
Sunil Thomas, Bruce A Luxon. Vaccines based on structure-based design provide protection against infectious diseases. Expert Review of Vaccines 2013; 12(11): 1301 doi: 10.1586/14760584.2013.840092
|
| 4 |
Aisha Q. Butt, Sinéad M. Miggin. Cancer and viruses: A double‐edged sword. PROTEOMICS 2012; 12(13): 2127 doi: 10.1002/pmic.201100526
|
| 5 |
Melanie B. Thomas, Marta Davila, James L. Abbruzzese. Stemming the Tide of Hepatitis B Virus–Related Hepatocellular Carcinoma?. Journal of Clinical Oncology 2008; 26(2): 172 doi: 10.1200/JCO.2007.14.4337
|
| 6 |
Sijia Yang, Xiao Ma, Hongxia Ni, Shaoying Zhou, Danbiao Hu, Honghui Shi, Xiaoying Chen, Hongjun Dong, Guozhang Xu. Safety, immunization coverage and determinants of a new kind of Hepatitis B vaccine firstly applied in Ningbo, China. Human Vaccines & Immunotherapeutics 2015; 11(12): 2819 doi: 10.1080/21645515.2015.1066946
|
| 7 |
Faseeha Noordeen, Sujitha Theneshkar, Shiyamalee Arunasalam. Protective immunity in a sample of healthy adults following vaccination with a more cost effective recombinant HBsAg vaccine. Journal of Clinical Virology Plus 2022; 2(1): 100056 doi: 10.1016/j.jcvp.2021.100056
|
| 8 |
Miguel W. Tregnaghi, Ricardo Voelker, Eduardo Santos-Lima, Betzana Zambrano. Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years. Vaccine 2010; 28(20): 3595 doi: 10.1016/j.vaccine.2010.02.049
|
| 9 |
Ashish Kumar. Hepatitis B virus infection and pregnancy: a practical approach. Indian Journal of Gastroenterology 2012; 31(2): 43 doi: 10.1007/s12664-012-0174-4
|
| 10 |
Sarah F. Schillie, Trudy V. Murphy. Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review. Vaccine 2013; 31(21): 2506 doi: 10.1016/j.vaccine.2012.12.012
|
| 11 |
Vijayakumar Velu, Ravi Dyavar Shetty, Marie Larsson, Esaki M Shankar. Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options. Retrovirology 2015; 12(1) doi: 10.1186/s12977-015-0144-x
|
| 12 |
Fuzhen Wang, Hui Zheng, Guomin Zhang, Zhengrong Ding, Fangjun Li, Ge Zhong, Yuansheng Chen, Yuanxi Jia, Ning Miao, Zhenhua Wu, Xiaojin Sun, Li Li, Xiaofeng Liang, Fuqiang Cui. Effectiveness of prevention of mother-to-child transmission practice in three provinces of Southern China. Human Vaccines & Immunotherapeutics 2015; 11(8): 2061 doi: 10.1080/21645515.2015.1023972
|
| 13 |
|
| 14 |
Chao-Shuang Lin, Shi-Bin Xie, Jing Liu, Zhi-Xin Zhao, Yu-Tian Chong, Zhi-Liang Gao. Effect of Revaccination Using Different Schemes among Adults with Low or Undetectable Anti-HBs Titers after Hepatitis B Virus Vaccination. Clinical and Vaccine Immunology 2010; 17(10): 1548 doi: 10.1128/CVI.00064-10
|
| 15 |
Fungi and Fungal Products in Human Welfare and Biotechnology. 2023; : 513 doi: 10.1007/978-981-19-8853-0_18
|
| 16 |
RJ Thomas, GJ Fletcher, H Kirupakaran, MP Chacko, S Thenmozhi, CE Eapen, G Chandy, P Abraham. Prevalence of non-responsiveness to an indigenous recombinant hepatitis B vaccine: A study among South Indian health care workers in a tertiary hospital. Indian Journal of Medical Microbiology 2015; 33: S32 doi: 10.4103/0255-0857.150877
|
| 17 |
Celine A. Hayden. Commercial Plant-Produced Recombinant Protein Products. Biotechnology in Agriculture and Forestry 2014; 68: 197 doi: 10.1007/978-3-662-43836-7_11
|